Peptides, Performance Retail, and Fitness Wearables

February 19, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

• Andrew Huberman calls retatrutide a potential trillion-dollar drug, showing 30% weight loss in Phase III trials with muscle preservation

• Lululemon launches Studio Yet. in LA, a three-week pop-up blending workouts with retail as stores become training extensions

• Garmin reports record Q4 revenue of $2.12B up 17%, with fitness segment climbing 42% driven by wearables demand

Joe Vennare is heading to LA this week for the Connected Health & Fitness Summit to host a fireside chat with Fritz Lanman, CEO of Playlist (parent company of Mindbody and ClassPass), on AI in fitness and the anticipated $7.5B EGYM merger. If you're attending or based in LA and want to meet up, email [email protected].

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.

Subscribe to our newsletter → insider.fitt.co/subscribe

Work with our recruiting firm → https://talent.fitt.co/

Follow us on Instagram → https://www.instagram.com/fittinsider/

Follow us on LinkedIn → linkedin.com/company/fittinsider

Reach out → [email protected]